---

Functional outcome of surgical management of calcaneal spur by excision and autologous platelet-rich plasma injection

Full Text PDF

---

Original Article

Author Details : Parvez Ahmad Ganie*, Arun Gulati, Rajendra Pranav Prasad, Anvith S Shetty

Volume : 7, Issue : 1, Year : 2021

Article Page : 34-37

https://doi.org/10.18231/j.ijor.2021.008

Suggest article by email

Get Permission

Abstract

Introduction: The calcaneal spur is also known as an enthesophyte which is a bony outgrowth from the calcaneum at the plantar fascia insertion. Treatment aspect ranges from initial conservative methods, invasive techniques to surgical excision of the spur in cases which are not responding to any other alternative methods. This article aims in evaluating the functional outcome of calcaneal spur excision coupled with a dose of autologous platelet-rich plasma injection in recalcitrant cases of the calcaneal spur.
Materials and Methods: A total of 42 cases of confirmed calcaneal spur cases were recruited for the study. All participants were offered with calcaneal excision with a dose of autologous platelet-rich plasma injection. All patients were evaluated preoperatively and post-operatively with VAS and FFI scores at the end of the 1st , 3rd; and 6th months.
Results: The patients who received calcaneal spur excision along with a single dose of autologous plateletrich plasma injection reported statistically significant pain relief at the end of 6 months while comparing with the pre-operative VAS score (p = 0.003) and FFI score showed a statistically significant functional outcome between both groups at the end of 6 months (p <0> Conclusion: Surgical removal of calcaneal spur along with a dose of an autologous platelet-rich plasma injection serve the better management for calcaneal spur and improves the functional quality of life.

Keywords: Calcaneal spur, Plateletrich plasma, VAS score.

How to cite : Ganie P A, Gulati A , Prasad R P, Shetty A S, Functional outcome of surgical management of calcaneal spur by excision and autologous platelet-rich plasma injection. IP Int J Orthop Rheumatol 2021;7(1):34-37

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution 4.0 International License, which allows others to remix, and build upon the work, the licensor cannot revoke these freedoms as long as you follow the license terms.